Concord Biotech (CONCORDBIO) — Board Meeting

Concord Biotech Limited announced its 41st AGM on July 31, 2026, where shareholders will vote on adopting FY25-26 financial statements, declaring a dividend of ₹7.55 per share, reappointing Ankur Vaid, and appointing Ekta Gupta as an independent director. The board seeks special resolution approval to increase loan guarantees to subsidiaries from ₹115 crore to ₹500 crore, with prior audit committee and board endorsement. Remote e-voting via CDSL runs from July 28 to 30, 2026, with a record date of July 24 for dividend eligibility. Shareholders must use mandatory passwords for CDSL access, and results will be published on company and CDSL websites. The filing emphasizes compliance with SEBI and MCA norms, with no material risks disclosed in related party transactions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CONCORDBIO ✨ Ask AI About This

About Concord Biotech Limited (CONCORDBIO)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹15,212.77 Cr P/E: 55.7 ROE: 13.5% ROCE: 18.1% Div Yield: 0.52%

View full CONCORDBIO stock details →

📡 Get AI alerts when CONCORDBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CONCORDBIO — Free

💡 Ask AI about this filing

"How does this board meeting affect Concord Biotech Limited's outlook?" "What did Concord Biotech Limited announce on 7 July 2026?" "Is this positive or negative for CONCORDBIO?"

Ask AI Free →

📊 More CONCORDBIO filings

See all CONCORDBIO filings →

🔥 Also filed on 7 July 2026

SHRIRAMFIN Shriram Finance Limited Corporate Action TATACAP Tata Capital Limited Corporate Action RSYSTEMS R Systems International Limited Announcement SHILPAMED Shilpa Medicare Limited Announcement SRGHFL SRG Housing Finance Limited Financial Results TICL Twamev Construction and Infrastructure Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CONCORDBIO files new disclosures

Track CONCORDBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CONCORDBIO — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd